Header Logo

Connection

CHRIS AMOS to Skin Neoplasms

Back to Details
This is a "connection" page, showing publications CHRIS AMOS has written about Skin Neoplasms.
CHRIS AMOS
Connection Strength
4.457
Skin Neoplasms
  1. Genetic variants in PDSS1 and SLC16A6 of the ketone body metabolic pathway predict cutaneous melanoma-specific survival. Mol Carcinog. 2020 06; 59(6):640-650.
    View in: PubMed
    Score: 0.379
  2. Identification of gene expression levels in primary melanoma associated with clinically meaningful characteristics. Melanoma Res. 2018 10; 28(5):380-389.
    View in: PubMed
    Score: 0.342
  3. Natural and orthogonal model for estimating gene-gene interactions applied to cutaneous melanoma. Hum Genet. 2014 May; 133(5):559-74.
    View in: PubMed
    Score: 0.244
  4. Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. Hum Mol Genet. 2011 Dec 15; 20(24):5012-23.
    View in: PubMed
    Score: 0.210
  5. DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance. JCO Precis Oncol. 2024 Nov; 8:e2400375.
    View in: PubMed
    Score: 0.131
  6. Methylation of nonessential genes in cutaneous melanoma - Rule Out hypothesis. Melanoma Res. 2023 06 01; 33(3):163-172.
    View in: PubMed
    Score: 0.116
  7. Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study. Pigment Cell Melanoma Res. 2022 11; 35(6):605-612.
    View in: PubMed
    Score: 0.112
  8. Genetic variants of SDCCAG8 and MAGI2 in mitosis-related pathway genes are independent predictors of cutaneous melanoma-specific survival. Cancer Sci. 2021 Oct; 112(10):4355-4364.
    View in: PubMed
    Score: 0.105
  9. Human genes differ by their UV sensitivity estimated through analysis of UV-induced silent mutations in melanoma. Hum Mutat. 2020 10; 41(10):1751-1760.
    View in: PubMed
    Score: 0.097
  10. Genetic variants in TKT and DERA in the nicotinamide adenine dinucleotide phosphate pathway predict melanoma survival. Eur J Cancer. 2020 09; 136:84-94.
    View in: PubMed
    Score: 0.097
  11. Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility. Nat Genet. 2020 05; 52(5):494-504.
    View in: PubMed
    Score: 0.095
  12. Genetic variants in the folate metabolic pathway genes predict cutaneous melanoma-specific survival. Br J Dermatol. 2020 10; 183(4):719-728.
    View in: PubMed
    Score: 0.094
  13. Genetic variants in glutamine metabolic pathway genes predict cutaneous melanoma-specific survival. Mol Carcinog. 2019 11; 58(11):2091-2103.
    View in: PubMed
    Score: 0.091
  14. Role of Immune Response, Inflammation, and Tumor Immune Response-Related Cytokines/Chemokines in Melanoma Progression. J Invest Dermatol. 2019 11; 139(11):2352-2358.e3.
    View in: PubMed
    Score: 0.090
  15. Genetic variants in the calcium signaling pathway genes are associated with cutaneous melanoma-specific survival. Carcinogenesis. 2019 04 29; 40(2):279-288.
    View in: PubMed
    Score: 0.089
  16. Genetic variants in ELOVL2 and HSD17B12 predict melanoma-specific survival. Int J Cancer. 2019 11 15; 145(10):2619-2628.
    View in: PubMed
    Score: 0.088
  17. A Leukocyte Infiltration Score Defined by a Gene Signature Predicts Melanoma Patient Prognosis. Mol Cancer Res. 2019 01; 17(1):109-119.
    View in: PubMed
    Score: 0.085
  18. Inverse Relationship between Vitiligo-Related Genes and Skin Cancer Risk. J Invest Dermatol. 2018 09; 138(9):2072-2075.
    View in: PubMed
    Score: 0.082
  19. Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival. Int J Cancer. 2018 06 01; 142(11):2303-2312.
    View in: PubMed
    Score: 0.081
  20. Genetic variants in the metzincin metallopeptidase family genes predict melanoma survival. Mol Carcinog. 2018 Jan; 57(1):22-31.
    View in: PubMed
    Score: 0.079
  21. A PGC1? genetic variant associated with nevus count and melanoma mortality. Int J Cancer. 2017 09 01; 141(5):1066-1067.
    View in: PubMed
    Score: 0.078
  22. Genetic variants in the genes encoding rho GTPases and related regulators predict cutaneous melanoma-specific survival. Int J Cancer. 2017 08 15; 141(4):721-730.
    View in: PubMed
    Score: 0.078
  23. Genetic Variants in WNT2B and BTRC Predict Melanoma Survival. J Invest Dermatol. 2017 08; 137(8):1749-1756.
    View in: PubMed
    Score: 0.078
  24. Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148. Nat Commun. 2017 05 02; 8:15034.
    View in: PubMed
    Score: 0.078
  25. Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma. Oncotarget. 2017 Mar 14; 8(11):17586-17592.
    View in: PubMed
    Score: 0.077
  26. Genetic variants in the integrin signaling pathway genes predict cutaneous melanoma survival. Int J Cancer. 2017 03 15; 140(6):1270-1279.
    View in: PubMed
    Score: 0.076
  27. Melanoma Expression Genes Identified through Genome-Wide Association Study of?Breslow Tumor Thickness. J Invest Dermatol. 2017 01; 137(1):253-257.
    View in: PubMed
    Score: 0.074
  28. Genetic variants in the vitamin D pathway genes VDBP and RXRA modulate cutaneous melanoma disease-specific survival. Pigment Cell Melanoma Res. 2016 Mar; 29(2):176-85.
    View in: PubMed
    Score: 0.071
  29. Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma. Nat Genet. 2015 Sep; 47(9):987-995.
    View in: PubMed
    Score: 0.069
  30. Integrated pathway and epistasis analysis reveals interactive effect of genetic variants at TERF1 and AFAP1L2 loci on melanoma risk. Int J Cancer. 2015 Oct 15; 137(8):1901-1909.
    View in: PubMed
    Score: 0.068
  31. Association of Common Genetic Polymorphisms with Melanoma Patient IL-12p40 Blood Levels, Risk, and Outcomes. J Invest Dermatol. 2015 Sep; 135(9):2266-2272.
    View in: PubMed
    Score: 0.067
  32. Genetic variants in fanconi anemia pathway genes BRCA2 and FANCA predict melanoma survival. J Invest Dermatol. 2015 Feb; 135(2):542-550.
    View in: PubMed
    Score: 0.065
  33. The effect on melanoma risk of genes previously associated with telomere length. J Natl Cancer Inst. 2014 Oct; 106(10).
    View in: PubMed
    Score: 0.065
  34. Identification of a melanoma susceptibility locus and somatic mutation in TET2. Carcinogenesis. 2014 Sep; 35(9):2097-101.
    View in: PubMed
    Score: 0.064
  35. Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans. Hum Mol Genet. 2013 Jul 15; 22(14):2948-59.
    View in: PubMed
    Score: 0.058
  36. Gene variants in angiogenesis and lymphangiogenesis and cutaneous melanoma progression. Cancer Epidemiol Biomarkers Prev. 2013 May; 22(5):827-34.
    View in: PubMed
    Score: 0.058
  37. Variants in melanocortin 1 receptor gene contribute to risk of melanoma--a direct sequencing analysis in a Texas population. Pigment Cell Melanoma Res. 2013 May; 26(3):422-5.
    View in: PubMed
    Score: 0.058
  38. Polymorphisms of nucleotide excision repair genes predict melanoma survival. J Invest Dermatol. 2013 Jul; 133(7):1813-21.
    View in: PubMed
    Score: 0.058
  39. Association between functional polymorphisms in genes involved in the MAPK signaling pathways and cutaneous melanoma risk. Carcinogenesis. 2013 Apr; 34(4):885-92.
    View in: PubMed
    Score: 0.057
  40. On the interplay of telomeres, nevi and the risk of melanoma. PLoS One. 2012; 7(12):e52466.
    View in: PubMed
    Score: 0.057
  41. PGC-1 coactivators regulate MITF and the tanning response. Mol Cell. 2013 Jan 10; 49(1):145-57.
    View in: PubMed
    Score: 0.057
  42. Preliminary evaluation of linkage between chromosome 1p markers and nevus densities in the Utah data. Cytogenet Cell Genet. 1992; 59(2-3):173-5.
    View in: PubMed
    Score: 0.054
  43. Genome-wide association study identifies three new melanoma susceptibility loci. Nat Genet. 2011 Oct 09; 43(11):1108-13.
    View in: PubMed
    Score: 0.053
  44. Genome-wide association study identifies novel alleles associated with risk of cutaneous basal cell carcinoma and squamous cell carcinoma. Hum Mol Genet. 2011 Sep 15; 20(18):3718-24.
    View in: PubMed
    Score: 0.052
  45. Genome-wide association study identifies nidogen 1 (NID1) as a susceptibility locus to cutaneous nevi and melanoma risk. Hum Mol Genet. 2011 Jul 01; 20(13):2673-9.
    View in: PubMed
    Score: 0.051
  46. In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis. J Natl Cancer Inst. 2005 Dec 21; 97(24):1822-31.
    View in: PubMed
    Score: 0.035
  47. Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma. J Natl Cancer Inst. 2003 Feb 19; 95(4):308-15.
    View in: PubMed
    Score: 0.029
  48. A comprehensive genome-wide analysis of melanoma Breslow thickness identifies interaction between CDC42 and SCIN genetic variants. Int J Cancer. 2016 11 01; 139(9):2012-20.
    View in: PubMed
    Score: 0.018
  49. Component-wise gradient boosting and false discovery control in survival analysis with high-dimensional covariates. Bioinformatics. 2016 Jan 01; 32(1):50-7.
    View in: PubMed
    Score: 0.017
  50. Functional Variants in Notch Pathway Genes NCOR2, NCSTN, and MAML2 Predict Survival of Patients with Cutaneous Melanoma. Cancer Epidemiol Biomarkers Prev. 2015 Jul; 24(7):1101-10.
    View in: PubMed
    Score: 0.017
  51. The relationship between blood IL-12p40 level and melanoma progression. Int J Cancer. 2015 Apr 15; 136(8):1874-80.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.